Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

ResMed|

Close the acquisition of MEDIFOX DAN, subject to regulatory clearances

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
14 Jun 2022
Due
31 Dec 2022
Delivered
21 Nov 2022
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The transaction is expected to close by the end of the second quarter of ResMed's fiscal year 2023 (December 31, 2022), subject to regulatory clearances.”
  • SourceResMed| Form 8-K press release, 2022-06-14
  • FilingSEC filing index
  • Deadline as statedby the end of the second quarter of ResMed's fiscal year 2023 (December 31, 2022)
  • Deadline used31 Dec 2022, the last day of the stated period
  • TypeTransaction
  • Permanent referenceKI-C-2022-RMD-006363
    Cite as https://keptindex.org/c/KI-C-2022-RMD-006363/ — this address never changes.

What we found

Evidence strength A What the grades mean

The filings state the MEDIFOX DAN acquisition completed on November 21, 2022, before the December 31, 2022 deadline.

  • A
    ResMed| 10-Q filed 2023-01-27 Regulatory filing · published 27 Jan 2023 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint 003f8c2574b4
    “which completed on November 21, 2022.” ✓ confirmed on the page
  • A
    ResMed| 10-K filed 2023-08-11 Regulatory filing · published 11 Aug 2023 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint 023f9ecb90fc
    “the Company acquired MediFox-Dan Investment GmbH and its subsidiaries (MEDIFOX DAN) on November 21, 2022” ✓ confirmed on the page

Market reaction: the shares moved -2.1% against the S&P 500 over the three sessions around the disclosure (26 Jan 2023 to 31 Jan 2023). What this measures

Checked 10 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Acquisition close
Indicative materiality
High rules
Action
Close
Deliverable
Acquisition of MEDIFOX DAN
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: subject to regulatory clearances
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you ResMed|? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2022-RMD-006363 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.